{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T14:24:53Z","timestamp":1793975093001,"version":"4.8.0"},"reference-count":21,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,12,1]],"date-time":"2026-12-01T00:00:00Z","timestamp":1796083200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,10,8]],"date-time":"2026-10-08T00:00:00Z","timestamp":1791417600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Metabolism Open"],"published-print":{"date-parts":[[2026,12]]},"DOI":"10.1016\/j.metop.2026.100508","type":"journal-article","created":{"date-parts":[[2026,10,10]],"date-time":"2026-10-10T06:34:36Z","timestamp":1791614076000},"page":"100508","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"special_numbering":"C","title":["Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study"],"prefix":"10.1016","volume":"32","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-0580-4989","authenticated-orcid":false,"given":"Aristomenis G.","family":"Alevizopoulos","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0008-0822-3280","authenticated-orcid":false,"given":"Georgios G.","family":"Anastasiou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0003-3212-0525","authenticated-orcid":false,"given":"Paraskevas","family":"Nomikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-3861-6268","authenticated-orcid":false,"given":"Iakovos","family":"Kritikos","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.metop.2026.100508_bib1","doi-asserted-by":"crossref","first-page":"200","DOI":"10.1016\/S0140-6736(19)32989-7","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132017: analysis for the global burden of disease study","volume":"395","author":"Rudd","year":"2020","journal-title":"Lancet"},{"issue":"12","key":"10.1016\/j.metop.2026.100508_bib2","doi-asserted-by":"crossref","first-page":"e2013","DOI":"10.1016\/S2214-109X(25)00356-0","article-title":"Global, regional, and national sepsis incidence and mortality, 1990\u20132021: a systematic analysis","volume":"13","author":"Gray","year":"2025","journal-title":"Lancet Global Health"},{"issue":"1","key":"10.1016\/j.metop.2026.100508_bib3","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1038\/nrgastro.2016.168","article-title":"Liver \u2014 guardian, modifier and target of sepsis","volume":"14","author":"Strnad","year":"2016","journal-title":"Nat Rev Gastroenterol Hepatol"},{"issue":"5","key":"10.1016\/j.metop.2026.100508_bib4","doi-asserted-by":"crossref","first-page":"235","DOI":"10.1186\/cc11381","article-title":"Clinical review: the liver in sepsis","volume":"16","author":"Nesseler","year":"2012","journal-title":"Crit Care"},{"issue":"3","key":"10.1016\/j.metop.2026.100508_bib5","doi-asserted-by":"crossref","first-page":"771","DOI":"10.2337\/dc10-1185","article-title":"Diabetes and sepsis: preclinical findings and clinical relevance","volume":"34","author":"Schuetz","year":"2011","journal-title":"Diabetes Care"},{"issue":"5","key":"10.1016\/j.metop.2026.100508_bib6","doi-asserted-by":"crossref","first-page":"413","DOI":"10.1111\/1440-1681.13073","article-title":"NF \u2010\u03baB as the mediator of metformin's effect on ageing and ageing\u2010related diseases","volume":"46","author":"Sultuybek","year":"2019","journal-title":"Clin Exp Pharmacol Physiol"},{"issue":"1","key":"10.1016\/j.metop.2026.100508_bib7","doi-asserted-by":"crossref","first-page":"365","DOI":"10.1016\/j.ymthe.2020.08.017","article-title":"DPP4\/CD32B\/NF-\u039aB circuit: a novel druggable target for inhibiting CRP-driven diabetic nephropathy","volume":"29","author":"Tang","year":"2020","journal-title":"Mol Ther"},{"issue":"12","key":"10.1016\/j.metop.2026.100508_bib8","doi-asserted-by":"crossref","first-page":"1113","DOI":"10.1056\/NEJMoa2028395","article-title":"A placebo-controlled trial of subcutaneous semaglutide in nonalcoholic steatohepatitis","volume":"384","author":"Newsome","year":"2020","journal-title":"N Engl J Med"},{"issue":"21","key":"10.1016\/j.metop.2026.100508_bib9","doi-asserted-by":"crossref","first-page":"2089","DOI":"10.1056\/NEJMoa2413258","article-title":"Phase 3 trial of semaglutide in metabolic dysfunction\u2013associated steatohepatitis","volume":"392","author":"Sanyal","year":"2025","journal-title":"N Engl J Med"},{"issue":"3","key":"10.1016\/j.metop.2026.100508_bib10","doi-asserted-by":"crossref","DOI":"10.1001\/jamanetworkopen.2022.1169","article-title":"Association of glucagon-like Peptide-1 receptor agonist vs dipeptidyl Peptidase-4 inhibitor use with mortality among patients with type 2 diabetes and advanced chronic kidney disease","volume":"5","author":"Chen","year":"2022","journal-title":"JAMA Netw Open"},{"issue":"5","key":"10.1016\/j.metop.2026.100508_bib11","doi-asserted-by":"crossref","DOI":"10.1371\/journal.pone.0323709","article-title":"Glucagon-like peptide 1 level and risk of death within 90 days after intensive care unit admission: a substudy of the IVOIRE cohort","volume":"20","author":"Jacquier","year":"2025","journal-title":"PLoS One"},{"issue":"1","key":"10.1016\/j.metop.2026.100508_bib12","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1038\/s41597-022-01899-x","article-title":"MIMIC-IV, a freely accessible electronic health record dataset","volume":"10","author":"Johnson","year":"2023","journal-title":"Sci Data"},{"issue":"1","key":"10.1016\/j.metop.2026.100508_bib13","doi-asserted-by":"crossref","DOI":"10.1038\/sdata.2018.178","article-title":"The eICU collaborative research database, a freely available multi-center database for critical care research","volume":"5","author":"Pollard","year":"2018","journal-title":"Sci Data"},{"key":"10.1016\/j.metop.2026.100508_bib14","series-title":"PhysioNet","article-title":"Northwestern ICU (NWICU) database","author":"Moukheiber","year":"2024"},{"issue":"9596","key":"10.1016\/j.metop.2026.100508_bib15","doi-asserted-by":"crossref","first-page":"1453","DOI":"10.1016\/S0140-6736(07)61602-X","article-title":"The strengthening the reporting of observational studies in epidemiology (STROBE) statement: guidelines for reporting observational studies","volume":"370","author":"Von Elm","year":"2007","journal-title":"Lancet"},{"issue":"8","key":"10.1016\/j.metop.2026.100508_bib16","doi-asserted-by":"crossref","first-page":"801","DOI":"10.1001\/jama.2016.0287","article-title":"The third international consensus definitions for sepsis and septic shock (SEpsis-3)","volume":"315","author":"Singer","year":"2016","journal-title":"JAMA"},{"issue":"19","key":"10.1016\/j.metop.2026.100508_bib17","doi-asserted-by":"crossref","first-page":"1737","DOI":"10.1056\/NEJMoa2102953","article-title":"New Creatinine- and cystatin C\u2013Based equations to estimate GFR without race","volume":"385","author":"Inker","year":"2021","journal-title":"N Engl J Med"},{"issue":"1","key":"10.1016\/j.metop.2026.100508_bib18","doi-asserted-by":"crossref","first-page":"289","DOI":"10.1111\/j.2517-6161.1995.tb02031.x","article-title":"Controlling the false discovery rate: a practical and powerful approach to multiple testing","volume":"57","author":"Benjamini","year":"1995","journal-title":"J Roy Stat Soc B"},{"issue":"4","key":"10.1016\/j.metop.2026.100508_bib19","doi-asserted-by":"crossref","first-page":"836","DOI":"10.1016\/j.jhep.2008.12.015","article-title":"MELD\u2013Na as a prognostic score for cirrhotic patients: hyponatremia and ascites are back in the game","volume":"50","author":"Samuel","year":"2009","journal-title":"J Hepatol"},{"issue":"4","key":"10.1016\/j.metop.2026.100508_bib20","doi-asserted-by":"crossref","first-page":"492","DOI":"10.1093\/aje\/kwm324","article-title":"Immortal time bias in pharmacoepidemiology","volume":"167","author":"Suissa","year":"2007","journal-title":"Am J Epidemiol"},{"key":"10.1016\/j.metop.2026.100508_bib21","doi-asserted-by":"crossref","first-page":"679","DOI":"10.1016\/S0140-6736(15)00803-X","article-title":"Liraglutide safety and efficacy in patients with non-alcoholic steatohepatitis (LEAN): a multicentre, double-blind, randomised, placebo-controlled phase 2 study","volume":"387","author":"Armstrong","year":"2015","journal-title":"Lancet"}],"container-title":["Metabolism Open"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000678?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2589936826000678?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,11,6]],"date-time":"2026-11-06T13:28:32Z","timestamp":1793971712000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2589936826000678"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,12]]},"references-count":21,"alternative-id":["S2589936826000678"],"URL":"https:\/\/doi.org\/10.1016\/j.metop.2026.100508","relation":{},"ISSN":["2589-9368"],"issn-type":[{"value":"2589-9368","type":"print"}],"subject":[],"published":{"date-parts":[[2026,12]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Hepatic biomarker trajectories and mortality in septic adults with type 2 diabetes and recorded dipeptidyl peptidase-4 inhibitor exposure versus metformin-based therapy: A propensity-score-matched cohort study","name":"articletitle","label":"Article Title"},{"value":"Metabolism Open","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.metop.2026.100508","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"100508"}}